Medical Condition News RSS Feed - Medical Condition News

Georgia State University-led study identifies structural brain abnormalities in schizophrenia patients

Georgia State University-led study identifies structural brain abnormalities in schizophrenia patients

Structural brain abnormalities in patients with schizophrenia, providing insight into how the condition may develop and respond to treatment, have been identified in an internationally collaborative study led by a Georgia State University scientist. [More]
Cognizin citicoline shows promise in patients with bipolar disorder and cocaine dependence

Cognizin citicoline shows promise in patients with bipolar disorder and cocaine dependence

The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks. [More]
NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners. [More]
New public guide addresses unrealistic expectations of screening tests

New public guide addresses unrealistic expectations of screening tests

Misconceptions about how screening works, its limitations and possible harms are still being perpetuated by media stories and high profile cases, such as Angelina Jolie's double mastectomy and emotive tabloid case studies of women under 25 dying from cervical cancer. [More]
Aspirin may inhibit the growth of mesothelioma, shows study

Aspirin may inhibit the growth of mesothelioma, shows study

Aspirin may inhibit the growth of mesothelioma, an aggressive and deadly asbestos-related cancer, University of Hawai'i Cancer Center researchers have found. [More]
Omega-3 fish oil supplements can improve cardiovascular health of healthy seniors

Omega-3 fish oil supplements can improve cardiovascular health of healthy seniors

Bethesda, Md. (July 6, 2015)—Fish oil is one of the most popular dietary supplements in the U.S. because of the perceived cardiovascular benefits of the omega-3 it contains. [More]
Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator. [More]
15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

For every life saved by Norway's Breast Cancer Screening Programme, five women are over-diagnosed, and have to go through an operation to remove a tumour that otherwise never would have caused problems. [More]
Changes in key biomarkers of Alzheimer’s disease during midlife may help predict future dementia risk

Changes in key biomarkers of Alzheimer’s disease during midlife may help predict future dementia risk

Studying brain scans and cerebrospinal fluid of healthy adults, scientists have shown that changes in key biomarkers of Alzheimer's disease during midlife may help identify those who will develop dementia years later, according to new research. [More]
Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

Tests have shown that a new cancer drug, FY26, is 49 times more potent than the clinically used treatment Cisplatin. [More]
Findings shed light on how symmetrical, round cells become asymmetrical and directional

Findings shed light on how symmetrical, round cells become asymmetrical and directional

When Greek mythology and cell biology meet, you get the protein Callipygian, recently discovered and named by researchers at The Johns Hopkins University for its role in determining which area of a cell becomes the back as it begins to move. [More]
Patients who receive intracranial stents at increased risk of experiencing another stroke

Patients who receive intracranial stents at increased risk of experiencing another stroke

The risk of experiencing another stroke is higher if patients, after dilation of their blood vessels in the brain, receive not only clot-inhibiting drugs, but also have stents inserted. The recently published results of the VISSIT study confirm this conclusion of a rapid report by the German Institute for Quality and Efficiency in Health Care (IQWiG) of October 2014. [More]
New WHO report focuses on raising taxes on tobacco, stamping out tobacco epidemic

New WHO report focuses on raising taxes on tobacco, stamping out tobacco epidemic

Too few governments levy appropriate levels of tax on cigarettes and other tobacco products. They therefore miss out on a proven, low-cost measure to curb demand for tobacco, save lives and generate funds for stronger health services, according to the "WHO Report on the global tobacco epidemic 2015". [More]
Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR). [More]
Study focuses on health risks from exposure to air pollution near roads and freeways

Study focuses on health risks from exposure to air pollution near roads and freeways

Policymakers and developers planning high-density housing near public transit with the goal of reducing automobile use and greenhouse gas emissions that contribute to global warming need a clearer understanding of the health risks from air pollution that may be created if that housing is also built near busy roads and freeways, according to new research by Keck School of Medicine of the University of Southern California scientists. [More]
Commercially available headphones unlikely to interfere with programmable shunt valve settings

Commercially available headphones unlikely to interfere with programmable shunt valve settings

Researchers at Brown University examined three magnetically programmable shunt valves to see if the magnetic field emissions of headphones can cause unintentional changes in shunt valve settings. Based on their findings, the researchers state that it is highly unlikely that commercially available headphones will interfere with programmable shunt valve settings. [More]
Mild head injury patients having lower serum S100B levels unlikely to have intracranial hemorrhage

Mild head injury patients having lower serum S100B levels unlikely to have intracranial hemorrhage

Researchers conducted a prospective observational study in elderly patients and adult patients receiving antiplatelet therapy who presented with mild head injury at two trauma hospitals in Vienna: the Trauma Hospital Meidling and the Donauspital. [More]
New research shows that risk of cardiovascular disease and early death falls due to vitamin C

New research shows that risk of cardiovascular disease and early death falls due to vitamin C

New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that high vitamin C concentrations in the blood from the intake of fruit and vegetables are associated with a reduced risk of cardiovascular disease and early death. [More]
City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine's biggest challenges: brain cancer. This month, they will launch a clinical trial using patients' own modified T cells to fight advanced brain tumors. [More]
Physical and psychological factors related to cognitive function vary in older women with ischemic stroke

Physical and psychological factors related to cognitive function vary in older women with ischemic stroke

An estimated 65 percent of ischemic stroke survivors experience cognitive impairment and decline. However, little is known about the varying roles of cognitive risk and protective factors before, during and after stroke. [More]
Advertisement
Advertisement